<p>Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies</p>Fiona H. Tan, Rodney B. Luwor|OncoTargets and Therapy|2019Cited by 197
Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivoRodney B. Luwor|Oncogene|2012Cited by 84
Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor GrowthFiona H. Tan, Rodney B. Luwor|Cancers|2018Cited by 25
Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 DysregulationFarah Ahmady, Rodney B. Luwor|Cells|2024Cited by 6
Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial–Mesenchymal Transition, and InvasionSarah F. Stuart, Rodney B. Luwor|Brain Sciences|2024Cited by 4